Hixon Zuercher LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 5,796 shares of the company’s stock, valued at approximately $2,356,000.
A number of other large investors have also recently made changes to their positions in the stock. Terra Nova Asset Management LLC raised its holdings in HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares during the period. Massmutual Trust Co. FSB ADV grew its holdings in HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares in the last quarter. Waldron Private Wealth LLC lifted its holdings in shares of HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after buying an additional 29 shares in the last quarter. Brookstone Capital Management increased its holdings in HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. grew its position in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Stock Up 1.0 %
Shares of NYSE:HCA opened at $366.66 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $226.44 and a 52-week high of $417.14. The stock has a market cap of $92.87 billion, a P/E ratio of 16.46, a price-to-earnings-growth ratio of 1.37 and a beta of 1.68. The business’s 50 day moving average is $392.01 and its 200 day moving average is $355.77. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.
HCA Healthcare Announces Dividend
Analysts Set New Price Targets
HCA has been the subject of several research analyst reports. Truist Financial raised their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Leerink Partners upped their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Royal Bank of Canada boosted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Finally, Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $379.11.
Get Our Latest Research Report on HCA Healthcare
Insider Activity at HCA Healthcare
In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.70% of the stock is owned by corporate insiders.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Trading Stocks: RSI and Why it’s Useful
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- What Are Growth Stocks and Investing in Them
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is NVIDIA-Backed SoundHound AI a Buy Ahead of Nov. 12 Earnings?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.